Atlas Trials

The Effect of SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Patients With Type 2 Diabetes

Clinical trial NCT05341388 · TERMINATED

Trial details

NCT number
NCT05341388
Sponsor
Goztepe Training and Research Hospital
Status
TERMINATED
Study type
OBSERVATIONAL
Type2 DiabetesCognitive Impairment
Start date
2021-03-01
Primary completion
2021-11-30
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.